Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS)

Abstract

Anticoagulants are a well known cause of drug-induced liver injury (DILI). We recently encountered a 45-year-old male who developed DILI during treatment with enoxaparin, a low-molecular-weight heparin (LMWH), for dural venous thrombosis. The man received enoxaparin 80 mg subcutaneously, twice daily. After 4 days, the patient was asymptomatic but he… (More)

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Hahn2015EnoxaparinInducedLI, title={Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS)}, author={Katherine J. Hahn and Shannon J. Morales and James H. Lewis}, booktitle={Drug safety - case reports}, year={2015} }